Export 141 results:
[ Author(Desc)] Keyword Title Type Year
Filters: Keyword is Animals  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
N. Bartolotti, Segura, L., and Lazarov, O., Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice., J Alzheimers Dis, vol. 50, no. 2, pp. 477-89, 2016.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
A. W. Bero, Yan, P., Roh, J. Hoon, Cirrito, J. R., Stewart, F. R., Raichle, M. E., Lee, J. - M., and Holtzman, D. M., Neuronal activity regulates the regional vulnerability to amyloid-β deposition., Nat Neurosci, vol. 14, no. 6, pp. 750-6, 2011.
K. Blennow and Zetterberg, H., The Past and the Future of Alzheimer's Disease Fluid Biomarkers., J Alzheimers Dis, vol. 62, no. 3, pp. 1125-1140, 2018.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo., J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
D. Brici, Götz, J., and Nisbet, R. M., A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles., J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
J. M. Castellano, Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., Goate, A. M., Bales, K. R., Paul, S. M., Bateman, R. J., and Holtzman, D. M., Human apoE isoforms differentially regulate brain amyloid-β peptide clearance., Sci Transl Med, vol. 3, no. 89, p. 89ra57, 2011.
M. Chakrabarti, McDonald, A. J., J Reed, W., Moss, M. A., Das, B. C., and Ray, S. K., Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
L. Chang, Zhang, Y., Liu, J., Song, Y., Lv, A., Li, Y., Zhou, W., Yan, Z., Almeida, O. F. X., and Wu, Y., Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons., J Alzheimers Dis, vol. 51, no. 1, pp. 197-212, 2016.
E. Chiziane, Telemann, H., Krueger, M., Adler, J., Arnhold, J., Alia, A., and Flemmig, J., Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 963-984, 2018.
D. Chu, Tan, J., Xie, S., Jin, N., Yin, X., Gong, C. - X., Iqbal, K., and Liu, F., GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner., J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
E. Vallino Costassa, Fiorini, M., Zanusso, G., Peletto, S., Acutis, P., Baioni, E., Maurella, C., Tagliavini, F., Catania, M., Gallo, M., Faro, M. Lo, Chieppa, M. Novella, Meloni, D., D'Angelo, A., Paciello, O., Ghidoni, R., Tonoli, E., Casalone, C., and Corona, C., Characterization of Amyloid-β Deposits in Bovine Brains., J Alzheimers Dis, vol. 51, no. 3, pp. 875-87, 2016.
M. L. Croze and Zimmer, L., Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms., J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.